A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

Clinical trial NCT06400472 · RECRUITING

Trial details

NCT number: NCT06400472
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Neoplasms Endometrial Neoplasms Uterine Cervical Neoplasms Carcinoma, Non-Small-Cell Lung Triple Negative Breast Neoplasms Pancreatic Neoplasm Colorectal Neoplasms

Start date: 2024-05-20
Primary completion: 2027-02-01
Enrollment: 495

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.